This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S pharmaceutical products, with a total ceiling value of $18,550.88 and a period of performance through September 10, 2024.
The contract was awarded on a firm-fixed price basis and does not have a set-aside designation. As a major supplier of pharmaceutical and medical products to the U.S. federal government, AmerisourceBergen is likely delivering these critical medications to support military treatment facilities, veterans' hospitals, and other government healthcare programs under the DLA's purview. The company has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, demonstrating its status as a key provider of essential medical commodities to the government.
Generated 12/9/24, 1:56 PM